Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use patented technology utilizing light and its remittance to view up to two millimeters beneath suspicious moles and lesions in a pain free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.


TSXV:MDX - Post by User

Comment by hobbs2969on Feb 27, 2024 10:58am
104 Views
Post# 35901367

RE:hobbs2969

RE:hobbs2969MDX has a tremendous product but do people want to pay out of pocket to find out that they have skin cancer or a cancerous mole?. Why was MDX never able to get OHIP to cover the cost of this procedure at the very start and then place Sciascopes in every other province and territory in Canada?  MDX should have placed a sciascope in every doctor's office in Canada for free. If an individual came to their doctor to see if they had a cancerous lesion, they could have had a picture of the lesion taken, and then received a report from a dermatologist within 72 hours and proceed to have the lesion removed at their convenience.. I can only assume that the Government of Ontario did not want to spend their health care money to identify and then remove a cancerous lesion at an early stage because if everyone accessed this service it may have cost them a ton of money. But if the cancer was diagnosed at stage four, the Government of Ontario would have to pay dearly for the cost of trying to save someone's life, and the patient would suffer unnecessarily. 
I sometimes wonder how the clinics in the Netherlands are doing. There must be 8 to 10 clinics that use the MDX Sciascope to detect cancer at an early stage. Do we ever hear about them? No. Do we ever hear about Brazil's implementation of the Sciascope? No again. What ever happened to implementation in Mexico? How about Italy and the United Arab Emirates?
MDX came up with the Sciascope, but failed in the implementation phase and for that I place the blame squarely on the shoulders of management.


 
<< Previous
Bullboard Posts
Next >>